JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01926-07v1
46/3/1098    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landry, M. L.
Right arrow Articles by Ferguson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landry, M. L.
Right arrow Articles by Ferguson, D.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2008, p. 1098-1100, Vol. 46, No. 3
0095-1137/08/$08.00+0     doi:10.1128/JCM.01926-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Prospective Study of Human Metapneumovirus Detection in Clinical Samples by Use of Light Diagnostics Direct Immunofluorescence Reagent and Real-Time PCR{triangledown}

Marie L. Landry,* Sandra Cohen, and David Ferguson

Department of Laboratory Medicine, Yale New Haven Hospital, and Yale University School of Medicine, New Haven, Connecticut

Received 28 September 2007/ Returned for modification 5 December 2007/ Accepted 20 December 2007

A Light Diagnostics human metapneumovirus (HMPV) monoclonal antibody reagent was evaluated using cytospin-enhanced direct immunofluorescence (DFA), and the results were compared to those for TaqMan reverse transcription-PCR (RT-PCR). Of the 202 samples tested, 48 were positive by RT-PCR, and 41 (85.4%) of these were positive by DFA (P = 0.0771). The commercial availability of an HMPV DFA reagent will be of significant benefit to clinical laboratories.

* Corresponding author. Mailing address: Department of Laboratory Medicine, P.O. Box 208035, Yale University School of Medicine, New Haven, CT 06520-8035. Phone: (203) 688-3475. Fax: (203) 688-8177. E-mail: marie.landry{at}yale.edu

{triangledown} Published ahead of print on 9 January 2008.

Journal of Clinical Microbiology, March 2008, p. 1098-1100, Vol. 46, No. 3
0095-1137/08/$08.00+0     doi:10.1128/JCM.01926-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.